Showing results (681-690 of 723) with videos related to

Sort By:
Pageof 73
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
American Heart Journal|February 28, 2016
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve ImplantationVincent Johan Nijenhuis, Naoual Bennaghmouch, Mariella Hassell, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
The British Journal of Surgery|March 4, 2022
Safety and economic analysis of selective histopathology following cholecystectomy: multicentre, prospective, cross-sectional FANCY studyVivian P Bastiaenen, Jaap L P van Vliet, Elise A J de Savornin Lohman, et al.
Open Heart|December 15, 2020
Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trialEnrico Fabris, Renicus Hermanides, Vincent Roolvink, et al.
International Journal of Cardiology|March 2, 2023
Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT)C Crooijmans, T P J Jansen, R E Konst, et al.
Thrombosis and Haemostasis|November 22, 2019
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC TrialAnne H Tavenier, Renicus S Hermanides, Enrico Fabris, et al.
Pageof 73